Bortezomib will improve the level or influence of flibanserin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Improved flibanserin adverse consequences could arise if coadministered with multiple weak CYP3A4 inhibitors. Critical: The drug info on this page is supposed for being academic. It is not a substitute for clinical information. https://mk-689211097.webdesign96.com/27234238/the-smart-trick-of-dup-747-that-nobody-is-discussing